Background: Acinetobacter baumannii is one of the most important nosocomial pathogens worldwide. This study aimed to use multilocus sequence typing (MLST) Approximately 85% of ST455 B /ST2 P bacteremia had a primary source of ventilation-associated pneumonia. Conclusion: We report the emergence in Taiwan of IRAB ST455   B   /ST2   P , which is the current predominant clone of IRAB in our hospital and has been causing bacteremia with high mortality in critical patients.
Background: Acinetobacter baumannii is one of the most important nosocomial pathogens worldwide. This study aimed to use multilocus sequence typing (MLST) for the epidemiological surveillance of A. baumannii isolates in Taiwan and analyze the clinical presentations and patients' outcome. Methods: MLST according to both Bartual's PubMLST and Pasteur's MLST schemes was applied to characterize bloodstream imipenem-resistant A. baumannii (IRAB) infection in intensive care units in a medical center. A total of 39 clinical IRAB bloodstream isolates in 2010 were enrolled. We also collected 13 imipenem-susceptible A. baumannii (ISAB) bloodstream isolates and 30 clinical sputum isolates (24 IRAB . In this hospital-based study, A. baumannii ST455 accounted for 38.5% of IRAB bacteremia, with a high mortality of 86.7%.
Introduction
Acinetobacter baumannii is one of the most important nosocomial pathogens worldwide, causing bacteremia, pneumonia, urinary tract infection, soft tissue infection, or intra-abdominal infection in hospitalized patients. 1 Bacteremia caused by imipenem-resistant A. baumannii (IRAB) has been associated with a higher mortality (46.0%) than bacteremia by imipenem-susceptible A. baumannii (ISAB; 28.3%) and other diagnoses of A. baumannii infection. 2 The most common source of A. baumannii infection was the respiratory tract, 1 but the relationship between respiratory tract infection and IRAB bacteremia remains unknown.
Multilocus sequence typing (MLST) is a widely used technique for bacterial typing, proven to provide unambiguous typing data for long-term and global A. baumannii epidemiological surveillance. 3 Two MLST schemes, Bartual's PubMLST and Pasteur's MLST schemes, were available in delineating the population structure of A. baumannii. This study, using MLST, was designed to characterize bloodstream IRAB infection of intensive care unit (ICU) patients in 2010 in a single medical center. We compared the result with those from bloodstream ISAB, and also IRAB and ISAB from sputum of patients with clinically confirmed ventilation-associated pneumonia (VAP).
Materials and methods

Study participants and inclusion criteria
This study was approved by the Institutional Review Board (100-3592B) of Chang Gung Memorial Hospital, Taoyuan, Taiwan. Charts were reviewed for ICU patients who were treated in Chang Gung Memorial Hospital in 2010 and had VAP ! 1 positive blood or sputum culture for A. baumannii, and symptoms and signs of infection. For patients with multiple episodes, only the first episode was included. Patients with incomplete medical records, younger than 18 years of age, or with polymicrobial infection were excluded.
Clinical data collection and definitions
Clinical data were retrospectively collected. VAP was defined as pneumonia with pulmonary infiltrates on chest radiographs, purulent tracheal secretions not less than 48 hours after intubation, and the start of mechanical ventilation 7, 8 "VAP as a primary source" was defined by the condition when at least one A. baumannii sputum isolate was found from patients with VAP prior to the development of bacteremia, which was proven via the isolation of an A. baumannii in blood. Mortality was defined as infectionattributable death, wherein the criteria of death were met before the symptoms and signs of bacteremia or pneumonia were resolved and with at least a blood or sputum culture positive for A. baumannii.
9 Appropriate antimicrobial therapy was defined as administering patients with at least one antimicrobial agent, except aminoglycoside, susceptible in vitro, within 2 days after bacteremia onset. 10 Culture detecting time was the interval (days) from culture sampling to reporting.
Bacterial isolates and antimicrobial susceptibility
Conventional biochemical tests and 16Se23S rRNA intergenic spacer region sequencing as described previously were used to characterize bacterial genospecies.
11 Antimicrobial susceptibility was determined by the disk diffusion method according to Clinical and Laboratory Standards Institute standards. 12 The minimum inhibitory concentration (MIC) of imipenem was further determined with Etest (Biomerieux, La Balmes les Grottes, France). The breakpoint for defining ISAB was an MIC of 4 mg/L, and a breakpoint of ! 8 mg/L for IRAB, including both intermediately resistant and resistant strains. 12 The tigecycline disk diffusion breakpoints was based on the FDA criteria (susceptible: ! 16 mm; resistant: 12 mm). 13 
MLST
In order to survey clonal relationships, methods of Bartual's PubMLST and Pasteur's MLST scheme were used. 4, 5 By Bartual's PubMLST method, seven standard housekeeping loci [citrate synthase (gltA), gyrase B (gyrB), glucose dehydrogenase B (gdhB), recombination A (recA), chaperone 60 (cpn60), glucose-6-phosphate isomerase (gpi), and RNA polymerase (rpoD)] were checked. 4 Sequences were compared with the A. baumannii database at the MLST database (http://pubmlst.org/abaumannii/) and conducted using BLAST. By the Pasteur's MLST scheme (www. pasteur.fr/recherche/genopole/PF8/mlst/Abaumannii. html), internal fragments of seven housekeeping genes [cpn60, protein elongation factor EF-G (fusA), gltA, CTP synthase (pyrG), recA, 50S ribosomal protein L2 (rplB), and RNA polymerase subunit B (rpoB)] were amplified and sequenced for each isolate. 5 The eBURST algorithm (http://eburst.mlst.net/) was used to analyze the genetic relationships of sequence types (STs).
14 Clonal complexes (CCs) were stringently defined as a cluster of STs having the same alleles at six among the seven loci and containing at least two STs.
14 Novel CCs were named by STs of their founders.
Pulsed-field gel electrophoresis
Isolates were analyzed by pulsed-field gel electrophoresis (PFGE) using methods as described elsewhere. 15 The fragment patterns obtained were interpreted as described by Tenover et al. 16 Briefly, isolates with no less than sevenband difference were considered to be different genotypes, which were arbitrarily designated in alphabetical order. Isolates with identical fingerprints and less than twoband difference were considered as the same genotype, whereas those with two-band to six-band difference were considered as subtypes of an existing genotype.
Polymerase chain reaction and sequencing
Primers specific for imipenem resistance genes (bla , bla OXA-40 , bla OXA-54 , bla OXA-58 , bla OXA-51 , bla ADC , bla IMP-1 , bla IMP-2 , bla VIM-1 , bla VIM-2 , and bla NDM-1 ), insertion sequences (ISAba1, ISAba2, ISAba3, ISAba4, and IS1008), and the AbaR4-type islands were designed, and polymerase chain reaction amplification and sequence determination were performed as described previously. 
Statistical analysis
Data analyses were performed using the SPSS software, version 17.0 (SPSS Inc., Chicago, IL, USA). We used Student t test, Chi-square test, or Fisher's exact test when appropriate to compare proportions. Variables with p < 0.2 in the univariate analysis were added in a forward stepwise manner and selected to create the final model for multivariable analysis. All statistical analyses were two-sided, and significance was set at p < 0.05.
Results
Clinical isolates
A total of 39 clinical IRAB bloodstream isolates in 2010 met the inclusion criteria and were enrolled in this cohort study (Table 1) . For comparison, 13 ISAB bloodstream isolates and 30 clinical sputum isolates (24 IRAB and 6 ISAB) fitting the inclusion criteria were also randomly collected (Tables 1 and 2 ).
STs, antimicrobial susceptibilities, and PFGE genotypes
There were 26 novel STs according to Bartual's PubMLST scheme in this study, including ST455, ST456, ST544eST556, and ST673eST683. These novel STs were newly found in Chang Gung Memorial Hospital, and registered in the following web site (id Z number of STs): http://pubmlst. org/. Most IRAB isolates (38.5% from bloodstream and 45.8% from sputum) belonged to ST455. ST455 isolates were susceptible to colistin (100%) and tigecycline (66.7%), but 86.7% were resistant to ampicillinesulbactam and 100% were resistant to all other antibiotics tested.
Most IRAB isolates belonged to CC92 and CC455 (bloodstream: CC455 48.7%, CC92 28.2%; sputum: CC455 62.5%, CC92 20.8%). In contrast to IRAB, few ISAB isolates (15.4% from bloodstream and 16.7% sputum) belonged to CC92 and no ISAB was in CC455. STs of ISAB were so diverse that 13 bloodstream isolates belonged to 11 different STs and six sputum isolates belonged to six different STs.
No difference was found in the ratio of ST455 among IRAB isolated from blood and sputum (15/39 vs. 11/24, p Z 0.564). Similar results were also found in all other STs (all p > 0.05).
More than half of the IRAB clinical isolates were found in the main evolutionary tract of CC92 to the novel CC455, descending from the founder ST208 to ST544, and then to ST455 ( Figure 1 ). It is notable that the attributable mortality in patients infected by these STs appeared higher and higher along the evolution (ST208: 33.3%; ST544: 75%; ST455: 86.7%); however, this should be evaluated further. ST544 is a one-locus variant of ST455 and a two-locus variant of ST92 (1-3-3-2-2-7-3). ST544, therefore, belonged to CC455 but not CC92.
By contrast, among the 39 IRAB isolates, 34 isolates (87.2%) belonged to ST2, three (7.7%) to ST129, one (2.6%) to ST217, and one (2.6%) to novel STN1 (Table 1) Among the 24 IRAB isolates from sputum, the upstream ISAba1 was found in two isolates (8.3%) with bla OXA-51-like and in 20 (83.3%) with bla OXA-23 , including 18 Tn2006 (ISAba1ebla OXA-23 eISAba1) in an AbaR4-type resistance island and two Tn2008 (ISAba1ebla OXA-23 ) ( Table 2 ). All of these isolates showed high-level resistance to imipenem (all MIC >32 mg/L). Tn2007 (ISAba4ebla OXA-23 ) was not found in these isolates. The upstream ISAba3 was found in one 
11-65-14-20-37-83-15 456 1 (2.6) 
Data are presented as n (%) or n/N (% (Table 3) .
In multivariate logistic regression analysis for mortality of the patents, infection by ST455 B and inappropriate initial antimicrobial therapy were statistically significant risk factors for mortality (Table 4) . For IRAB bacteremia, patients given appropriate therapy (early effective antibiotics administered in 2 days) had a lower mortality (31.2%) than those given inappropriate therapy (late therapy or therapy with ineffective agents; 82.6%; p Z 0.002). The mean culture reporting time was 3 days.
Patients with IRAB bacteremia showed higher mortality (26/39, 66.7%) than those with ISAB bacteremia (3/13, 23.1%; p Z 0.009). Patients with IRAB bacteremia showed higher mortality (26/39, 66.7%) than those with only IRAB pneumonia (8/24, 33.3%; p Z 0.018). Patients with ST455 bacteremia showed higher mortality (13/15, 86.7%) than those with non-ST455 bacteremia (16/37, 43.2%; p Z 0.005).
Discussion
Although the Pasteur scheme was considered to be the gold standard of the MLST method in typing A. baumannii, 6 we found in this study that ST455 B /ST2 P can only be differentiated from non-ST455 B /ST2 P by using the Bartual scheme. ST455 B was first reported in Taiwan, but it has been reported to be the predominant clone among A. baumannii isolates collected from 12 hospitals throughout Japan.
20
ST455 also appeared in southern Taiwan (C.H. Chiu, unpublished data). As the population structure of A. baumannii seems to be highly diverse, 21 it is important to use an MLST scheme with a higher level of resolution to identify any tiny but significant difference. In our study, nine different STs (ST455, ST544, ST545, ST208, ST436, ST191, ST473, ST546, and ST547) by the Bartual scheme could not be differentiated using the Pasteur scheme, and thus all these nine different ST P belonged to ST2 B . However, ST455 B /ST2 P infection showed a significantly higher attributable mortality than non-ST455 B /ST2 P ( Table 3 ). The .8) important clinical difference can only be found by using the Bartual scheme rather than the Pasteur scheme. All ST455 B /ST2 P isolates were collected from patients in ICUs in our hospital during a 12-month period. We have observed no temporal or geographic association among these isolates. No outbreak was found. By contrast, PFGE genotypes 1e7 could only be differentiated by different MLST genotypes using the Bartual scheme rather than the Pasteur scheme.
Although the Bartual scheme was an important MLST method for genotyping A. baumannii worldwide, 4, 6 no data were found with this method in Taiwan. Fifteen isolates in 2006 was analyzed using only the Pasteur scheme in Taiwan Surveillance of Antimicrobial Resistance study, and all belonged to ST2 P . 22 In the other study, a total of 19 MLST types defined by the Pasteur scheme were found among the 87 isolates examined in 2010. 23 The predominant MLST genotype, ST2 P , was identified in 42 isolates and ST129 P in 25 isolates. 23 Likewise, ST2 P and ST129 P were the major STs in isolates in this study. Again, the Bartual scheme has never been used in previous studies, and identification of novel, clinically significant STs using the Bartual scheme was not possible in previous as well as current studies. 22, 23 Most isolates in this study belonged to CC92 B /CC2 P , which is currently the most prevalent clonal complex worldwide. 6, 24 Currently, most clinical isolates in Asia, United States, and Australia belonged to CC92 and carried bla OXA-23 .
25e29 AbaR4-type resistance islands that carried bla OXA-23 were detected in IRAB isolates from most Asian countries. 25 In China, ST92 was the most prevalent clone and was found in every province in that country. 26, 27 It is apparent that the reason for the rapidly increasing carbapenem resistance in China was the wide dissemination of imipenem-resistant, bla OXA-23-like -producing CC92, especially ST92, ST75, and ST138. 27 By contrast, carbapenemsusceptible isolates in China had a more diverse genetic background. 27 In the United States, ST122 and ST208 were the most common and were found in four of the six hospitals surveyed in previous studies. 28, 29 Carbapenemaseencoding genes bla OXA-23 and/or ISAba1-bla OXA-51-like were present among the majority of these isolates. First reported in Pittsburgh, St. Louis, Los Angeles, and Las Vegas in the United States between 2008 and 2009, 28 ST208 was the founder of our isolates belonging to CC92. ST208 was also found in Denmark, 30 Egypt, and China (http:// pubmlst.org/abaumannii/). In Australia, most clinical isolates of A. baumannii also belonged to ST92 and carried bla OXA-23 . 24 IRAB appeared more diverse in South America. islands widely distributed in CC92 were also found in different CCs. In Brazil, CC104, CC109, and CC113 were found as predominant clones. 33 Most IRAB isolates (72%) carried the bla OXA-23-like gene in Brazil.
31 CC104 and CC113
were also found to be common in Argentina. AbaR-type genomic islands have been detected in most multidrugresistant A. baumannii isolates (36/51) in Argentina, Uruguay, and Chile since 1986. 32 CC113, CC103, and ST25 Data are presented as mean AE SD or n (%). *All variables with a p value < 0.20 in the univariate analysis were considered to be included in the logistic regression model in the multivariate analysis. A forward stepwise selection process was used. We found that only infection by ST455 and inappropriate initial therapy were statistically significant risk factors for mortality. APACHE II Z Acute Physiology and Chronic Health Evaluation II; CI Z confidence interval; IRAB Z imipenem-resistant Acinetobacter baumannii.
were the major clones in Buenos Aires and Rosario, and most of these clones carried bla OXA-23-like . 33 We identified 26 novel ST B and five novel CC B in this study. Novel ST455 B , contributing to 38.5% of IRAB bacteremia, resulted in 86.7% attributable mortality in a cohort of patients. A possible explanation for the successful spread of ST455 in the hospitals is that they have a selective advantage over other strains. Antimicrobial resistance is one such advantage, and we found that all of ST455 isolates showed high imipenem resistance (MIC > 16 mg/L) as well as resistance to all other tested antibiotics except colistin and tigecycline. In addition to 33.3% isolates carrying Tn2008 or ISAba1ebla OXA-51 , 66.7% of ST455 bloodstream isolates carriedTn2006 in an AbaR4-type resistance island. It is difficult to give effective antibiotics for treating ST455 infection in 2 days prior to culture reporting (mean, 3 days). No administration of appropriate drugs in time apparently resulted in high mortality among patients infected by ST455. This clone might become a threat to public health because higher attributable mortality, higher APACHE II score, and higher Pitt bacteremia score were found from patients with ST455 B /ST2 P infection. Increased virulence of this clone deduced from this result warrants further studies.
The majority of IRABST455 isolates showed a common imipenem resistance genetic determinant, ISAba1ebla OXA-23 eISAba1 (Tn2006), located in an AbaR4-type resistance island. Our previous study indicated that in Taiwan this transposon had become the most common carbapenem resistance gene in A. baumannii since 2009 and has replaced ISAba1ebla OXA-51 , the predominant resistance mechanism from 1993 to 2007. 17, 19 ST455 bacteremia appeared to originate from VAP based on three findings of this study: first, > 85% of ST455 bacteremia had a primary source of VAP; second, no significant difference was found in the distribution of STs and carbapenemase genes between blood isolates from bacteremic patients and sputum isolates from patients with VAP; and third, all three paired isolates from blood and sputum of the same patients showed the same MLST and PFGE genotype, including two patients infected by ST455 (PFGE type 1) and one by ST544 (PFGE type 2).
In conclusion, A. baumannii has become the most common pathogen for nosocomial bloodstream infection in ICUs in Taiwan since 2009. 19 ST455 B /ST2 P , the predominant clone of IRAB identified in this study, has been posing a significant threat to patients' health and has the potential to cause a regional or global spread, given its highly pathogenic and resistant nature. Continued surveillance is necessary. It is also important to detect and use effective drugs to treat ST455 B /ST2 P infection earlier at the stage of VAP rather than in bacteremic stage to decrease the mortality rate.
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